Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CSF2 |
| Upstream (Parents) |
|---|
| (<<) BCL2A1 → CSF2 |
| (<<) CASP8 → CSF2 |
| (<<) CDCP1 → CSF2 |
| (<<) CDK8 → CSF2 |
| (<<) EDNRA → CSF2 |
| (<<) FZD5 → CSF2 |
| (<<) GBP2 → CSF2 |
| (<<) MAL → CSF2 |
| (<<) MYL3 → CSF2 |
| (<<) NCOA3 → CSF2 |
| (<<) NFKB2 → CSF2 |
| (<<) PLAU → CSF2 |
| (<<) STAT5A → CSF2 |
| (<<) WNT5A → CSF2 |
| Downstream (Children) |
|---|
| CSF2 → EMILIN2 (>>) |
| CSF2 → EPHA1 (>>) |
| CSF2 → RARG (>>) |
| CSF2 → RXRB (>>) |
| CSF2 → TPM3 (>>) |
| CSF2 → UBE2D1 (>>) |
| CSF2 → ZBED2 (>>) |
